Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Vir Biotech IPO: What You Need To Know
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology, Inc.: Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022 EORTC/NCI/AACR Symposium
Puma Wins 5-Year Extension of Patent on Main Breast Cancer Treatment Drug Nerlynx - Los Angeles Business Journal
Alan Auerbach: Puma Biotech's Overnight Billionaire - Forbes India
Puma Biotechnology shares rocket after biopharma zips past Street's 4Q estimate
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters
Reverse Mergers Losing Out to Lower-Cost Offerings - TheStreet
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib | Nasdaq
Puma Biotechnology - Crunchbase Company Profile & Funding